APEX1 and metabolic dysfunction-associated steatotic liver disease: Among the polymorphisms of APEX1 examined in our research, i.e., c.-468T>G (rs1760944) and c.444T>G (rs1130409), the latter had the greatest association with the risk of NAFLD.